Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
Researchers from L V Prasad Eye Institute (LVPEI), Indian Institute of Technology-Hyderabad (IITH), and the Centre for Cellular and Molecular Biology (CCMB), have collaborated to develop a 3D-printed cornea from the human donor corneal tissue.
EXAMIANS